Global Premature Ejaculation Market 2014-2018

世界の早漏症(PE)治療薬市場

◆タイトル:Global Premature Ejaculation Market 2014-2018
◆商品コード:IRTNTR4315
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2014年10月1日
◆ページ数:54
◆資料形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Five UserUSD2,800 ⇒換算¥316,400見積依頼/購入/質問フォーム
Enterprise License(社内共有可)USD3,500 ⇒換算¥395,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

本調査レポートでは、"世界の早漏症(PE)治療薬市場"について調査・分析し、エグゼクティブサマリー、市場概観、市場規模及び予測、作用機序別分析、投与経路(ROA)別分析、主要地域別分析、市場シェア、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析等の情報をお届けいたします。

About Premature Ejaculation
Premature ejaculation is a common sexual dysfunction in men, which is characterized by early discharge of semen. Premature ejaculation can be diagnosed through IELT, which is the average time taken by a man to ejaculate during sexual intercourse. There are two types of premature ejaculation: Primary premature ejaculation and secondary premature ejaculation.

TechNavio’s analysts forecast the Global Premature Ejaculation market to grow at a CAGR of 10.20 percent over the period 2013-2018.

Covered in this Report
This report covers the present scenario and the growth prospects of the Global Premature Ejaculation market for the period 2014–2018. To calculate the market size, the report considers the revenue generated from the sales of various drugs used in the treatment of premature ejaculation that are available in the market.
The report also presents the vendor landscape and a corresponding detailed analysis of the top four vendors in the Global Premature Ejaculation market. In addition, the report discusses the major drivers that influence the growth of the market and outlines the challenges faced by the vendors and the market at large.

TechNavio’s report, the Global Premature Ejaculation Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, the APAC and EMEA regions; it also covers the Global Premature Ejaculation market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions
• Americas
• APAC
• EMEA

Key Vendors
• Absorption Pharmaceuticals
• Furiex Pharmaceuticals
• Innovus Pharmaceuticals
• Plethora Solutions

Other Prominent Vendors
• Bayer
• Dong-A Pharmaceutical
• Dong-A ST
• Eli Lilly
• Emcure
• Endo
• Futura Medical
• GlaxoSmithKline
• Medisyn
• Menarini
• NeuroHealing
• Pfizer
• Shionogi
• Symyoo
• Vectura
• Vyrix

Market Driver
• Presence of Unmet Need
• For a full, detailed list, view our report

Market Challenge
• Unknown Etiology
• For a full, detailed list, view our report

Market Trend
• Rise in Awareness
• For a full, detailed list, view our report

Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

【資料の目次】

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Product Profiles
04.1 Promescent
04.2 Priligy
04.3 EjectDelay
04.4 Tempe
05. Market Research Methodology
05.1 Market Research Process
05.2 Research Methodology
06. Introduction
07. Disease Overview and Management
07.1 Disease Overview
07.1.1 Disease Classification
07.1.2 Epidemiology
07.2 Management of Premature Ejaculation
07.2.1 Diagnosis
07.2.2 Management of Premature Ejaculation
08. Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 Five Forces Analysis
09. Market Segmentation by Route of Administration
09.1 Oral
09.2 Topical
10. Market Segmentation by Dosage Form
10.1 Solid
10.2 Liquid
10.3 Semi-solid
11. Market Segmentation by Mechanism of Action
11.1 SSRI
11.2 Amide Anesthetics
11.3 PDE5 Inhibitors
12. Geographical Segmentation
13. Buying Criteria
14. Market Growth Drivers
15. Drivers and their Impact
16. Market Challenges
17. Impact of Drivers and Challenges
18. Market Trends
19. Trends and their Impact
20. Vendor Landscape
20.1 Competitive Scenario
20.1.1 Key News
20.1.2 Mergers and Acquisitions
20.2 Market Share Analysis 2013
20.3 Other and Future Prominent Vendors
21. Pipeline Portfolio
21.1 Key Information about the Pipeline Drugs
22. Key Vendor Analysis
22.1 Absorption Pharmaceuticals
22.1.1 Key Facts
22.1.2 Business Overview
22.1.3 SWOT Analysis
22.2 Furiex
22.2.1 Key Facts
22.2.2 Business Overview
22.2.3 Business Strategy
22.2.4 SWOT Analysis
22.3 Innovus
22.3.1 Key Facts
22.3.2 Business Overview
22.3.3 Business Strategy
22.3.4 SWOT Analysis
22.4 Plethora Solutions
22.4.1 Key Facts
22.4.2 Business Overview
22.4.3 SWOT Analysis
23. Other Reports in this Series

List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Recommendations to Diagnose Premature Ejaculation
Exhibit 3: Global Premature Ejaculation Market 2013-2018 (US$ million)
Exhibit 4: Global Premature Ejaculation Market Segmentation by Route of Administration
Exhibit 5: Global Premature Ejaculation Market Segmentation by Route of Administration
Exhibit 6: Global Premature Ejaculation Market Segmentation by Dosage Form
Exhibit 7: Global Premature Ejaculation Market Segmentation by Dosage Form
Exhibit 8: Global Premature Ejaculation Market Segmentation by Mechanism of Action
Exhibit 9: Global Premature Ejaculation Market Segmentation by Mechanism of Action
Exhibit 10: Global Premature Ejaculation Market by Geographical Segmentation
Exhibit 11: Snapshot of the Pipeline Drugs for Premature Ejaculation



【掲載企業】

Absorption Pharmaceuticals , Furiex Pharmaceuticals , Innovus Pharmaceuticals , Plethora Solutions , Bayer, Dong-A Pharmaceutical, Dong-A ST, Eli Lilly, Emcure, Endo, Futura Medical, GlaxoSmithKline, Medisyn, Menarini, NeuroHealing, Pfizer, Shionogi, Symyoo, Vectura,Vyrix

【資料のキーワード】

早漏症(PE)、治療薬、製薬、医薬品

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[世界の早漏症(PE)治療薬市場] (Global Premature Ejaculation Market 2014-2018 / IRTNTR4315)販売に関する免責事項
[世界の早漏症(PE)治療薬市場] (Global Premature Ejaculation Market 2014-2018 / IRTNTR4315)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆